The impact of non- and anthracycline-based chemotherapy on fatigue in breast cancer survivors: results from WF-97415.
Nancy E AvisBeverly J LevineHeidi D KlepinShannon L MihalkoPeter H BrubakerTonya MooreAmy C LaddSusan F DentMary Helen HackneyBonnie KyWilliam O NtimLynne I WagnerKathryn E WeaverW Gregory Hundleynull nullPublished in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2024)
Women with breast cancer who receive non- or anthracycline-based chemotherapy experience similar trends in and levels of fatigue within the first year of treatment and greater fatigue than women receiving AIs alone or women without breast cancer.
Keyphrases
- polycystic ovary syndrome
- sleep quality
- breast cancer risk
- locally advanced
- pregnancy outcomes
- cervical cancer screening
- squamous cell carcinoma
- type diabetes
- pregnant women
- insulin resistance
- rectal cancer
- combination therapy
- chemotherapy induced
- skeletal muscle
- replacement therapy
- smoking cessation
- childhood cancer